Continuous Glucose Monitoring (CGM) devices have been recently approved by FDA to be used in the type 1 diabetes (T1D) treatment non-adjunctively, i.e. without confirmatory fingerstick (SMBG) measurements (Edelman, JDST, 2017). Consequently, how to tune insulin bolus relying also on glucose rate of change (ROC), has become of particular interest. Our aim is to evaluate extensively in silico empirical literature methods proposed for such a scope.

In Silico Assessment of Literature Methods to Adjust Insulin Bolus Dose according to CGM Trend

Francesca Marturano
;
Giacomo Cappon
;
Martina Vettoretti;Andrea Facchinetti;Giovanni Sparacino
2017

Abstract

Continuous Glucose Monitoring (CGM) devices have been recently approved by FDA to be used in the type 1 diabetes (T1D) treatment non-adjunctively, i.e. without confirmatory fingerstick (SMBG) measurements (Edelman, JDST, 2017). Consequently, how to tune insulin bolus relying also on glucose rate of change (ROC), has become of particular interest. Our aim is to evaluate extensively in silico empirical literature methods proposed for such a scope.
2017
Diabetes Technology Meeting, DTM 2017
DIABETES TECHNOLOGY MEETING
File in questo prodotto:
File Dimensione Formato  
abstract_Marturano_DTM2017.pdf

accesso aperto

Descrizione: Abstract
Tipologia: Abstract
Licenza: Accesso libero
Dimensione 143.18 kB
Formato Adobe PDF
143.18 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3271817
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact